Antibiotic sulfadiazine degradation by persulfate oxidation : Intermediates dependence of ecotoxicity and the induction of antibiotic resistance genes

Copyright © 2022 Elsevier Ltd. All rights reserved..

To preserve the water resources, this study has analyzed the ecotoxicity and antibiotic resistance genes (ARGs) induction capacity of sulfadiazine degradation intermediates resulting from persulfate activation oxidation enhanced by ultraviolet, ultrasound and microwave. The five degradation pathways caused by the contribution discrepancy of electron transfer and singlet oxygen (1O2) and variations in the ecotoxicity of different degradation products were analyzed. Microcosm experiment exhibited that the microbial community in actual water changed significantly with SDZ and degradation intermediates, in which the dominant genera were Aeromonas, Cupriavidus, Elizabethkingia and Achromobacter. Except for the selective pressure on bacteria, the degradation intermediates also exert a certain degree or even stronger induction on sulfonamide ARGs (sul4, sul1 and sul2) than SDZ. Furthermore, the potential hosts for sulfonamide ARGs were revealed by network analysis. These results provide a better understanding of antibiotics degradation mechanism and ARGs occurrence, which is useful for controlling the spread of ARGs.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:368

Enthalten in:

Bioresource technology - 368(2023) vom: 01. Jan., Seite 128306

Sprache:

Englisch

Beteiligte Personen:

Zheng, Heshan [VerfasserIn]
Zhang, Yunfei [VerfasserIn]
Li, Shuo [VerfasserIn]
Feng, Xiaochi [VerfasserIn]
Wu, Qinglian [VerfasserIn]
Kit Leong, Yoong [VerfasserIn]
Chang, Jo-Shu [VerfasserIn]

Links:

Volltext

Themen:

0N7609K889
Anti-Bacterial Agents
Antibiotic
Antibiotic resistance genes
Degradation mechanisms
Ecotoxicity
Journal Article
Metagenomics
Sulfadiazine
Sulfonamides

Anmerkungen:

Date Completed 02.12.2022

Date Revised 02.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.biortech.2022.128306

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348858981